Viktor Curovic-Rotbain
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials.
Journal: Diabetes, obesity & metabolism
Published: March 28, 2026
Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three-Dimensional Vascular Ultrasound.
Journal: Diabetes, obesity & metabolism
Published: December 15, 2025
Slowing the progression of diabetic and non-diabetic kidney disease: A summary of the current evidence base for sodium-glucose co-transporter-2 inhibitors.
Journal: Diabetes, obesity & metabolism
Published: August 14, 2024
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study.
Journal: Diabetes, obesity & metabolism
Published: July 23, 2024
Understanding the interplay between chronic lymphocytic leukemia and type 2 diabetes.
Journal: Expert review of hematology
Published: July 23, 2024
Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular disease.
Journal: Journal of diabetes and its complications
Published: May 31, 2024
Performance of new and panel CKD-EPI equations in European adults with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: January 02, 2024
Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes.
Journal: BMJ open diabetes research & care
Published: December 12, 2023
Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis.
Journal: Journal of diabetes and its complications
Published: October 07, 2023
Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled study.
Journal: Diabetes, obesity & metabolism
Published: July 05, 2023
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: April 28, 2023
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial.
Journal: Diabetes, obesity & metabolism
Published: March 20, 2023
Last Updated: 09/26/2026